STEADY II
Research type
Research Study
Full title
Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY)- Stage 2
IRAS ID
290033
Contact name
Marietta Stadler
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
1 years, 10 months, 28 days
Research summary
There is currently no effective intervention for type 1 diabetes and eating disorders. The main objective of STEADY Stage 2 is to test the feasibility of the newly developed STEADY intervention.
STEADY was co-designed by using EBCD methodology and other qualitative methods (focus groups, interviews). These findings informed the development of a T1DM cognitive behaviour therapy (CBT) manual. The intervention will now be tested in a feasibility Randomised Controlled Trial (RCT) in adults with type 1 diabetes and eating disorders and compared with usual clinical care. If STEADY is feasible, this may provide an effective intervention for this population.This study will take place at King's College London, with PIC sites at Guy's and St Thomas' NHS foundation trust, Royal Free London NHS Foundation Trust, South London and Maudsley NHS Foundation Trust, Imperial College NHS foundation trust, Barts Health NHS foundation Trust, Bournemouth and Christchurch NHS Foundation Trust Diabetes service, Vincent Square Eating Disorder Service,
Participants will remain in the study for 6 months, with a 12-month extended observation period. The study is expected to end in February 2023.
REC name
East of England - Essex Research Ethics Committee
REC reference
21/EE/0235
Date of REC Opinion
25 Nov 2021
REC opinion
Further Information Favourable Opinion